CVS vs TDOC
CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences. TDOC: A global virtual care and mental health platform that orchestrates telehealth delivery for 100+ million insured members and direct-to-consumer mental health counseling, facing headwinds from market saturation and reimbursement pressures.
Side-by-side fundamentals
| Metric | CVS | TDOC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $108.08 | $8.92 | |
| Market cap as of 2026-07-23 | $140.4B | $1.6B | |
| P/E as of 2026-07-23 | 47.90 | n/a | |
| PEG as of 2026-07-23 | 3.33 | n/a | |
| Net margin as of 2026-07-23 | +0.7% | -6.8% | CVS higher |
| Gross margin as of 2026-07-23 | +13.9% | +69.3% | TDOC higher |
| Operating margin as of 2026-07-23 | +1.6% | -8.1% | CVS higher |
| ROE as of 2026-07-23 | +3.9% | -12.4% | CVS higher |
| ROA as of 2026-07-23 | +1.1% | -6.0% | CVS higher |
| Debt / equity as of 2026-07-23 | 0.81 | 0.75 | TDOC lower |
| Revenue growth (YoY) as of 2026-07-23 | +7.6% | -1.5% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +1.7% | CVS higher |
| Dividend yield as of 2026-07-23 | +2.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.59 | 2.11 | |
| 1-year return as of 2026-07-22 close | +76.9% | +5.9% | CVS higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.